Targeting benign prostate hyperplasia treatments: AR/TGF-β/NOX4 inhibition by apocynin suppresses inflammation and proliferation
Author:
Funder
Korea Health Industry Development Institute
National Research Foundation of Korea
Ministry of Science, ICT and Future Planning
Ministry of Health and Welfare
Publisher
Elsevier BV
Subject
Multidisciplinary
Reference51 articles.
1. The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019;Awedew;The Lancet Healthy Longevity,2022
2. Benign prostatic hyperplasia;Ng;Stat Treasure Island (Florida): Pearls,2022
3. Decoding ceRNA regulatory network and autophagy-related genes in benign prostatic hyperplasia;Zhou;Int J Biol Macromol,2023
4. Androgen receptor signaling–mitochondrial DNA–oxidative phosphorylation: A critical triangle in early prostate cancer;Sakellakis;Curr Urol,2022
5. Oxidative stress in ageing and chronic degenerative pathologies: molecular mechanisms involved in counteracting oxidative stress and chronic inflammation;Leyane;Int J Mol Sci,2022
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Research Progress on the Mechanism of Chinese Herbal Compounds Treating Benign Prostatic Hyperplasia by Regulating Inflammatory Response;Integrative Medicine in Nephrology and Andrology;2024-08-21
2. Isolation of Potent 5α-Reductase Inhibitors and Antioxidants from Sphaeranthus indicus Linn. for the Management of Benign Prostatic Hyperplasia;Plant Foods for Human Nutrition;2024-08-19
3. Gut microbiome: a novel preventive and therapeutic target for prostatic disease;Frontiers in Cellular and Infection Microbiology;2024-07-29
4. Patient-Derived Conditionally Reprogrammed Cells in Prostate Cancer Research;Cells;2024-06-08
5. New Pimarane Diterpenoids Isolated from EtOAc-Extract of Apiospora arundinis Culture Medium Show Antibenign Prostatic Hyperplasia Potential;ACS Omega;2024-01-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3